Innovent Biologics1801 
$5.421.20%24h
1.20%24h
Global rank1742
Market cap$8.73B
Change 7d1.08%
YTD Performance-0.59%
SP500 benchmarkUnderperform
P/E0
P/S0
Revenue$0
Earnings$0
Dividend yield-
Main Sector
Healthcare
Market capitalization of Innovent Biologics (1801)
As of September 2024, Innovent Biologics has a market cap of $8.73B. This makes Innovent Biologics the world's 1742th valuable company by market cap, according to our data. The market capitalization, also known as a stock market cap is a key financial indication. It represents the combined worth of all the outstanding shares of a publicly traded company multiplied by the current stock price. This figure is often used to see how much a company is worth. This figure is often used to see what is the company net worth.
Market cap history of Innovent Biologics from 2018 to 2024
-
Value:-
Market cap history of Innovent Biologics from 2018 to 2024
| Year | Market Cap | Change |
|---|---|---|
| 2024 | $7.70B | -12.75% |
| 2023 | $8.83B | 27.61% |
| 2022 | $6.92B | -30.57% |
| 2021 | $9.97B | -41.73% |
| 2020 | $17.10B | 211.86% |
| 2019 | $5.48B | 10.17% |
| 2018 | $4.98B | - |
1801 Market Cap Today is $8.73B 1.20% - 11 Sept 2024
View largest stocks by market cap 
